Literature DB >> 32741903

The Latest Strategy for Keloid and Hypertrophic Scar Prevention and Treatment: The Nippon Medical School (NMS) Protocol.

Rei Ogawa1, Teruyuki Dohi1, Mamiko Tosa1, Masayo Aoki1, Satoshi Akaishi1.   

Abstract

In 2006, we established a scar/keloid-specialized unit in the Department of Plastic, Reconstructive, and Aesthetic Surgery at Nippon Medical School (NMS) in Tokyo, Japan. In the ensuing 15 years, we treated approximately 2,000 new scar/keloid patients annually. This extensive experience has greatly improved the efficacy of the treatments we offer. Therefore, we discuss here the latest NMS protocol for preventing and treating keloids and hypertrophic scars. While this protocol was optimized for Japanese patients, our experience with a growing body of non-Japanese patients suggests that it is also effective in other ethnicities. The extensive evidence-based experience underlying the NMS protocol suggests that it may be suitable as the foundation of a standard international prevention/treatment algorithm for pathological scars.

Entities:  

Keywords:  hypertrophic scar; keloid; wound

Mesh:

Substances:

Year:  2020        PMID: 32741903     DOI: 10.1272/jnms.JNMS.2021_88-106

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  3 in total

1.  Hemodynamics and Vascular Histology of Keloid Tissues and Anatomy of Nearby Blood Vessels.

Authors:  Shigeyoshi Eura; Junichi Nakao; Takeshi Iimura; Shizuko Ichinose; Chiemi Kaku; Teruyuki Dohi; Satoshi Akaishi; Mamiko Tosa; Rei Ogawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-06-10

Review 2.  Efficacy of the Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Keloid and Hypertrophic Scars: A Systematic Review and Meta-analysis.

Authors:  Lingfeng Pan; Haiyan Qin; Caihong Li; Guang Zhang; Liehao Yang; Lianbo Zhang
Journal:  Aesthetic Plast Surg       Date:  2022-01-21       Impact factor: 2.708

3.  Identification and characterization of four immune-related signatures in keloid.

Authors:  Xiaoxiang Wang; Bo Liang; Jiehua Li; Xiaobing Pi; Peng Zhang; Xinzhu Zhou; Xiaodong Chen; Sitong Zhou; Ronghua Yang
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.